Healthcare

in committee · United States · House Jul 21, 2025

HR 4569: Supporting Premature Infant Nutrition Act of 2025

This bill requires Medicaid, Children's Health Insurance Program (CHIP), and private health plans to cover human milk fortifier - specialized nutritional products made from donor human milk - without cost-sharing for eligible premature infants. It directly affects infants under 1 year with specific medical needs, such as birth at 34 weeks or less, birth weight under 1,800 grams, or certain health conditions requiring this fortifier. Key provisions mandate no deductibles or copays for this coverage starting January 1, 2026, and define eligibility criteria for healthcare providers to determine medical necessity. The law applies broadly across federal health programs and private insurance, ensuring access to this nutrition support for qualifying infants.

Topics ✓ HealthcareSupports HealthcareMandates no cost-sharing for human milk fortifier under Medicaid/CHIP, expanding essential nutrition access for premature infants with medical needs.95% confidence

Sub-Topics Children's Health Insurance Medicaid

Track

in committee · United States · House Feb 18, 2025

HR 1414: Cameron’s Law

HR 1414, titled "Cameron’s Law," increases the tax credit for pharmaceutical companies developing orphan drugs (medicines for rare diseases) from 25% to 50% of qualified research expenses. This change directly affects drug manufacturers investing in treatments for conditions affecting fewer than 200,000 people in the U.S. The bill amends the Internal Revenue Code to implement this higher credit rate, effective for taxable years starting after the law’s enactment. It provides a concrete financial incentive to encourage research into rare disease treatments without altering eligibility criteria or adding new requirements.

Topics ✓ Budget & TaxesSupports Budget & TaxesBill increases tax credit for pharmaceutical companies from 25% to 50%, providing direct tax relief via amended tax code, aligning with tax policy support indicators.95% confidence ✓ HealthcareSupports HealthcareIncreases tax credit for orphan drug R&D, incentivizing treatments for rare diseases. Directly funds healthcare innovation and improves patient access to rare disease therapies.95% confidence

Sub-Topics Tax Credits

Track

in committee · United States · Senate Feb 24, 2026

S 1441: SAVES Act of 2025

The SAVES Act of 2025 establishes a five-year pilot program at the Department of Veterans Affairs (VA) to fund nonprofit organizations that provide service dogs to eligible veterans with specific disabilities, such as blindness, mobility issues, PTSD, or traumatic brain injury. Nonprofits must apply competitively, meet training and animal welfare standards (including ADA compliance), and provide service dogs at no cost to veterans, with the VA covering all program expenses. The VA will also provide ongoing veterinary insurance for the dogs, which continues even after the pilot ends. This program is funded with $10 million annually for five years, targeting veterans as defined by VA medical criteria.

Topics ✓ Budget & TaxesSupports Budget & TaxesBill allocates federal funds to establish a pilot program for service dogs, directly increasing funding for a public service.85% confidence ✓ HealthcareSupports HealthcareProvides VA-funded service dogs for veterans with PTSD (mental health condition), directly supporting mental health services through therapeutic assistance.95% confidence ✓ VeteransSupports VeteransFunds VA pilot program providing service dogs to veterans with disabilities at no cost, expanding access to critical support services95% confidence

Sub-Topics Veteran Mental Health

Track

in committee · United States · Senate Apr 10, 2025

S 1095: Stop STALLING Act

The Stop STALLING Act empowers the Federal Trade Commission (FTC) to take action against pharmaceutical companies that submit "sham" petitions under drug approval processes. Specifically, it targets petitions that are objectively baseless and used to delay generic drug approvals, directly affecting drug manufacturers filing such petitions. The bill establishes civil penalties of up to $50,000 per day or the revenue earned from the delayed drug during the petition's review period. It creates a presumption of "sham" status if the Health Secretary determines a petition was filed primarily to delay approval, with companies able to rebut this presumption. The law does not alter FDA drug approval rules but adds FTC enforcement for unfair competition tactics.

Topics ✓ HealthcareSupports HealthcareTargets delays in generic drug approvals, lowering costs and improving patient access to affordable medications by penalizing sham petitions that prolong brand-name drug dominance.90% confidence

Track

in committee · United States · House Mar 31, 2025

HRES 276: Raising awareness of the racial disparities in the impact of colorectal cancer on the Hispanic community.

HRES 276 is a non-binding resolution recognizing racial disparities in colorectal cancer outcomes for the Hispanic community. It specifically highlights that Hispanic adults are less likely to receive screening (49% vs. 58% for non-Hispanic White adults) despite colorectal cancer being a leading cause of cancer death in this group. The resolution encourages the CDC to research screening disparities and develop strategies to reduce them, while also supporting National Colorectal Cancer Awareness Month in March. It urges individuals to discuss screening with healthcare providers and calls for NIH research on risk factors in young adults. This resolution does not create new laws or funding but aims to raise awareness and guide future public health efforts.

Topics ✓ HealthcareSupports HealthcareBill explicitly addresses racial disparities in colorectal cancer screening (a public health issue), encourages CDC research to improve access, and aims to reduce health inequities for Hispanic communities.95% confidence

Sub-Topics Public Health

Track

in committee · United States · House Sep 15, 2025

HR 5364: STOP FRAUD in Medicaid Act

HR 5364, the STOP FRAUD in Medicaid Act, expands state Medicaid fraud control units' authority to investigate and prosecute fraud committed by Medicaid beneficiaries (people receiving benefits), not just healthcare providers. It amends federal law to explicitly include "individuals applying for or receiving" Medicaid services in fraud investigations, requiring states to cover both provider and beneficiary fraud. The bill directs states to investigate false applications or misuse of benefits, such as lying about income to qualify or using benefits for unauthorized services. These changes take effect 180 days after the bill becomes law, applying to all Medicaid programs nationwide. The law focuses on clarifying investigative scope without creating new penalties or funding.

Topics ✓ HealthcareSupports HealthcareBill protects Medicaid program integrity by preventing beneficiary fraud, aligning with 'protect' indicator under healthcare support.85% confidence

Sub-Topics Medicaid

Track

in committee · United States · Senate Sep 30, 2025

S 2951: Competitive Bidding Relief Act

S 2951, the Competitive Bidding Relief Act, extends current Medicare payment rates for durable medical equipment (DME) in non-rural areas through December 31, 2025, and delays a new payment rule until 2026. It directly affects Medicare beneficiaries and DME suppliers in non-rural communities by maintaining existing reimbursement rates. The bill modifies how the Medicare program calculates payments under Section 414.210(g)(9) of federal regulations, preventing immediate changes to payment structures. This provides temporary stability for DME providers while allowing the government time to implement future adjustments.

Topics ✓ HealthcareSupports HealthcareExtends current Medicare DME payment rates, preventing potential rate cuts for beneficiaries and suppliers, thus protecting existing healthcare funding and access.95% confidence

Sub-Topics Medicare

Track

in committee · United States · Senate Apr 1, 2025

S 1227: ABC Act

S 1227 (ABC Act) requires the Centers for Medicare & Medicaid Services and Social Security Administration to review and simplify eligibility processes, forms, and communications for Medicare, Medicaid, CHIP, and Social Security programs. It directly affects family caregivers - defined as individuals supporting people with disabilities or health needs - who often face duplicate paperwork and communication barriers when navigating these systems. Key provisions mandate reducing repeated information requests, improving website accessibility (including ADA compliance), cutting call wait times, providing translation services, and gathering input from caregivers and advocacy groups. The agencies must report findings and proposed improvements to Congress within two years, with follow-up reports every two years. This bill focuses on streamlining existing processes, not creating new benefits or funding.

Topics ✓ HealthcareSupports HealthcareBill simplifies Medicare/Medicaid eligibility processes, reduces duplicate paperwork for caregivers, and improves access to healthcare programs, directly advancing patient access and system efficiency.90% confidence

Sub-Topics Children's Health Medicaid Medicare

Track

in committee · United States · House Mar 4, 2025

HR 668: Coordinating Care for Senior Veterans and Wounded Warriors Act

HR 668 establishes a 3-year pilot program to coordinate healthcare between the Department of Veterans Affairs (VA) and Medicare for veterans enrolled in both systems (called "covered veterans"). It assigns each participating veteran a VA case manager to create personalized care plans, navigate VA and Medicare services, and coordinate medical records to improve access, outcomes, and cost efficiency. The program tracks specific metrics like care costs, patient satisfaction, and service gaps, and requires quarterly reports to Congress on its implementation and results. The pilot will operate across 3-5 VA facilities in diverse settings (rural, urban, medically underserved areas) to test coordination models before potentially expanding the approach.

Topics ✓ HealthcareSupports HealthcareEstablishes VA-Medicare coordination pilot to improve veteran healthcare access, outcomes, and cost efficiency through personalized care plans and case managers.95% confidence ✓ VeteransSupports VeteransEstablishes VA-Medicare coordination pilot with case managers to improve veterans' healthcare access, outcomes, and cost efficiency for enrolled veterans.95% confidence

Sub-Topics Long-Term Care Medicare Veteran Benefits Veteran Healthcare Veteran Mental Health Tags Seniors

Track

in committee · United States · Senate Mar 12, 2025

S 983: Hearing Device Coverage Clarification Act

The Hearing Device Coverage Clarification Act (S 983) requires the Centers for Medicare & Medicaid Services (CMS) to clarify that implanted active middle ear hearing devices are prosthetics - not hearing aids - so they fall under Medicare's prosthetic coverage instead of the hearing aid exclusion. This change would directly affect Medicare beneficiaries who use these specific devices, ensuring they qualify for coverage without being denied under current policy. CMS must issue this clarification within 60 days of the bill's enactment, referencing the existing regulatory definition of "prosthetic" from 42 CFR § 414.202. The bill does not create new benefits but removes a coverage barrier for these devices.

Topics ✓ HealthcareSupports HealthcareBill expands Medicare coverage by reclassifying devices as prosthetics (not hearing aids), ensuring beneficiaries qualify for coverage they were previously denied under current policy.95% confidence

Sub-Topics Medicaid Medicare

Track